Non-statin therapies for CKD with dyslipidemia

Abstract

We will review data from the general population concerning the individual therapeutic interventions and complement that with information specific to chronic kidney disease when available. We will focus on treatment interventions that are specifically targeting lipid disorders, namely therapeutic lifestyle changes, fibrates, nicotinic acid, bile acid sequestrants, omega-3 fatty acids (fish oil), and inhibitors of cholesteryl ester transfer protein. Other, non-specific interventions (optimal treatment of diabetes, reducing proteinuria with the use of ACEI, optimizing medication use) will not be covered here.